{"id":12067,"date":"2025-07-22T08:24:08","date_gmt":"2025-07-22T12:24:08","guid":{"rendered":"https:\/\/www.rigicon.com\/glossary-term\/active-monitoring\/"},"modified":"2026-10-06T18:04:24","modified_gmt":"2026-10-06T22:04:24","slug":"monitorizacion-activa","status":"publish","type":"glossary-term","link":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/","title":{"rendered":"Monitorizaci\u00f3n Activa"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","glossary-category":[126],"glossary-product":[],"class_list":["post-12067","glossary-term","type-glossary-term","status-publish","hentry","glossary-category-urological-conditions"],"acf":{"gt-definition":"<p>La monitorizaci\u00f3n activa, tambi\u00e9n conocida como vigilancia activa, es una estrategia que consiste en observar de cerca una afecci\u00f3n sin tratamiento inmediato e intervenir solo si se produce una progresi\u00f3n.<sup>1<\/sup> Este enfoque implica un seguimiento peri\u00f3dico mediante pruebas y exploraciones programadas para detectar cualquier cambio en la afecci\u00f3n.<sup>2<\/sup> Se utiliza principalmente en afecciones de crecimiento lento o que suponen un riesgo inmediato m\u00ednimo, sobre todo en los casos en que los posibles efectos secundarios del tratamiento podr\u00edan superar los beneficios de una intervenci\u00f3n inmediata.<sup>3<\/sup> La monitorizaci\u00f3n activa permite a los profesionales sanitarios retrasar o evitar tratamientos innecesarios, manteniendo al mismo tiempo la capacidad de intervenir con rapidez si la afecci\u00f3n empeora.<sup>4<\/sup> Este enfoque se aplica con mayor frecuencia en el tratamiento del c\u00e1ncer de pr\u00f3stata de bajo riesgo, pero tambi\u00e9n puede aplicarse a otras afecciones.<sup>5<\/sup><\/p>","gt-synonyms":"Vigilancia activa, espera vigilante, manejo expectante, observaci\u00f3n, protocolo de vigilancia, protocolo de seguimiento, tratamiento diferido","gt-citation":"[1] Cooperberg MR, Meeks W, Fang R, Gaylis FD, Catalona WJ, Makarov DV. Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US. JAMA Netw Open. 2023;6(3):e231439. DOI: 10.1001\/jamanetworkopen.2023.1439\n\n[2] National Cancer Institute. Definition of active surveillance. Cancer.gov. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/active-surveillance. Accessed June 2, 2025.\n\n[3] Mayo Clinic. Active surveillance for prostate cancer. https:\/\/www.mayoclinic.org\/tests-procedures\/active-surveillance-for-prostate-cancer\/about\/pac-20384946. Updated November 15, 2023. Accessed June 2, 2025.\n\n[4] American Cancer Society. Observation or Active Surveillance for Prostate Cancer. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/treating\/watchful-waiting.html. Updated November 22, 2023. Accessed June 2, 2025.\n\n[5] Moore CM, King LE, Withington J, et al. Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting. Eur Urol Oncol. 2023;6(2):160-182. DOI: 10.1016\/j.euo.2023.01.003. PMID: 36710133.","gt-clinical-context":"<p>La monitorizaci\u00f3n activa se utiliza principalmente en contextos cl\u00ednicos en los que una intervenci\u00f3n inmediata puede no ser necesaria ni beneficiosa.<sup>1<\/sup> Su aplicaci\u00f3n m\u00e1s frecuente es el tratamiento del c\u00e1ncer de pr\u00f3stata de bajo riesgo, en el que se ha convertido en el enfoque de elecci\u00f3n seg\u00fan las principales gu\u00edas cl\u00ednicas.<sup>2<\/sup> Esta estrategia es especialmente adecuada para pacientes con tumores peque\u00f1os y de crecimiento lento, localizados en una zona concreta y que no causan s\u00edntomas.<sup>3<\/sup><\/p>\n\n<p>Los criterios de selecci\u00f3n de los pacientes para la monitorizaci\u00f3n activa suelen incluir:<\/p>\n<ul>\n    <li>Clasificaci\u00f3n de la enfermedad como de bajo riesgo (p. ej., puntuaci\u00f3n de Gleason baja en el c\u00e1ncer de pr\u00f3stata)<sup>4<\/sup><\/li>\n    <li>Extensi\u00f3n limitada de la enfermedad (p. ej., localizada en una sola zona)<sup>3<\/sup><\/li>\n    <li>Ausencia de s\u00edntomas relacionados con la afecci\u00f3n<sup>3<\/sup><\/li>\n    <li>Consideraci\u00f3n de la edad del paciente y de las comorbilidades que podr\u00edan limitar la esperanza de vida<sup>4<\/sup><\/li>\n<\/ul>\n\n<p>El protocolo de seguimiento suele incluir:<\/p>\n<ul>\n    <li>Visitas m\u00e9dicas peri\u00f3dicas (normalmente cada 3-6 meses)<sup>4<\/sup><\/li>\n    <li>An\u00e1lisis de sangre peri\u00f3dicos (p. ej., determinaci\u00f3n del PSA en el c\u00e1ncer de pr\u00f3stata)<sup>4<\/sup><\/li>\n    <li>Estudios de imagen a intervalos definidos (p. ej., RM)<sup>5<\/sup><\/li>\n    <li>Biopsias de repetici\u00f3n cuando est\u00e9n indicadas por cambios en otros par\u00e1metros<sup>5<\/sup><\/li>\n<\/ul>\n\n<p>Los resultados esperados con la monitorizaci\u00f3n activa incluyen:<\/p>\n<ul>\n    <li>Evitar efectos secundarios innecesarios del tratamiento en muchos pacientes<sup>4<\/sup><\/li>\n    <li>Preservaci\u00f3n de la calidad de vida durante el per\u00edodo de seguimiento<sup>4<\/sup><\/li>\n    <li>Ausencia de un impacto significativo en la supervivencia espec\u00edfica por c\u00e1ncer en los pacientes adecuadamente seleccionados<sup>5<\/sup><\/li>\n    <li>Posibilidad de una intervenci\u00f3n diferida si se detecta progresi\u00f3n<sup>5<\/sup><\/li>\n<\/ul>\n\n<p>La decisi\u00f3n de pasar de la monitorizaci\u00f3n activa al tratamiento activo suele basarse en signos de progresi\u00f3n de la enfermedad, como el aumento de los niveles de biomarcadores, cambios en los hallazgos de imagen o el empeoramiento de los s\u00edntomas.<sup>5<\/sup><\/p>","gt-related-evidence":null,"gt-featured":true,"gt-ai-referenced":false,"gt-view-count":102},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.7 (Yoast SEO v28.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Monitorizaci\u00f3n Activa<\/title>\n<meta name=\"description\" content=\"La monitorizaci\u00f3n activa permite vigilar estrechamente ciertas patolog\u00edas urol\u00f3gicas, evitando tratamientos inmediatos invasivos si no son necesarios.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Monitorizaci\u00f3n Activa - Prosthetic Urology Glossary\" \/>\n<meta property=\"og:description\" content=\"Explore Rigicon\u2019s evidence-based glossary covering penile implants, AUS, ED treatments, and surgical terms in prosthetic urology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/\" \/>\n<meta property=\"og:site_name\" content=\"Rigicon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rigiconurology\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-06T22:04:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/05\/header-d.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"718\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@rigiconurology\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/monitorizacion-activa\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/monitorizacion-activa\\\/\",\"name\":\"Monitorizaci\u00f3n Activa\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#website\"},\"datePublished\":\"2025-07-22T12:24:08+00:00\",\"dateModified\":\"2026-10-06T22:04:24+00:00\",\"description\":\"La monitorizaci\u00f3n activa permite vigilar estrechamente ciertas patolog\u00edas urol\u00f3gicas, evitando tratamientos inmediatos invasivos si no son necesarios.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/monitorizacion-activa\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/monitorizacion-activa\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/monitorizacion-activa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glossary Terms\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/urology-glossary\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Monitorizaci\u00f3n Activa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/\",\"name\":\"Rigicon\",\"description\":\"Innovative Urological Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#organization\"},\"alternateName\":\"Innovative Urological Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#organization\",\"name\":\"Rigicon, Inc.\",\"alternateName\":\"Innovative Urological Solutions\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"width\":512,\"height\":512,\"caption\":\"Rigicon, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/x.com\\\/rigiconurology\",\"https:\\\/\\\/www.instagram.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@Rigicon\\\/podcasts\",\"https:\\\/\\\/www.youtube.com\\\/Rigicon\",\"https:\\\/\\\/www.threads.com\\\/@rigiconurology\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rigicon\\\/\",\"https:\\\/\\\/www.wikidata.org\\\/wiki\\\/Q141595822\"],\"description\":\"Rigicon es un fabricante especializado con sede en EE. UU. de dispositivos de urolog\u00eda prot\u00e9sica: pr\u00f3tesis de pene, esf\u00ednteres urinarios artificiales y pr\u00f3tesis testiculares, comercializados en m\u00e1s de 75 pa\u00edses.\",\"email\":\"operations@rigicon.com\",\"telephone\":\"+1 (888) 202-9790\",\"legalName\":\"Rigicon, Inc.\",\"vatID\":\"81-3545645\",\"taxID\":\"81-3545645\",\"duns\":\"045247683\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Monitorizaci\u00f3n Activa","description":"La monitorizaci\u00f3n activa permite vigilar estrechamente ciertas patolog\u00edas urol\u00f3gicas, evitando tratamientos inmediatos invasivos si no son necesarios.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/","og_locale":"es_ES","og_type":"article","og_title":"Monitorizaci\u00f3n Activa - Prosthetic Urology Glossary","og_description":"Explore Rigicon\u2019s evidence-based glossary covering penile implants, AUS, ED treatments, and surgical terms in prosthetic urology.","og_url":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/","og_site_name":"Rigicon","article_publisher":"https:\/\/www.facebook.com\/rigiconurology\/","article_modified_time":"2026-10-06T22:04:24+00:00","og_image":[{"width":1440,"height":718,"url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/05\/header-d.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@rigiconurology","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/","url":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/","name":"Monitorizaci\u00f3n Activa","isPartOf":{"@id":"https:\/\/www.rigicon.com\/es\/#website"},"datePublished":"2025-07-22T12:24:08+00:00","dateModified":"2026-10-06T22:04:24+00:00","description":"La monitorizaci\u00f3n activa permite vigilar estrechamente ciertas patolog\u00edas urol\u00f3gicas, evitando tratamientos inmediatos invasivos si no son necesarios.","breadcrumb":{"@id":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.rigicon.com\/es\/"},{"@type":"ListItem","position":2,"name":"Glossary Terms","item":"https:\/\/www.rigicon.com\/es\/urology-glossary\/"},{"@type":"ListItem","position":3,"name":"Monitorizaci\u00f3n Activa"}]},{"@type":"WebSite","@id":"https:\/\/www.rigicon.com\/es\/#website","url":"https:\/\/www.rigicon.com\/es\/","name":"Rigicon","description":"Innovative Urological Solutions","publisher":{"@id":"https:\/\/www.rigicon.com\/es\/#organization"},"alternateName":"Innovative Urological Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rigicon.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.rigicon.com\/es\/#organization","name":"Rigicon, Inc.","alternateName":"Innovative Urological Solutions","url":"https:\/\/www.rigicon.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.rigicon.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","contentUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","width":512,"height":512,"caption":"Rigicon, Inc."},"image":{"@id":"https:\/\/www.rigicon.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rigiconurology\/","https:\/\/x.com\/rigiconurology","https:\/\/www.instagram.com\/rigiconurology\/","https:\/\/www.youtube.com\/@Rigicon\/podcasts","https:\/\/www.youtube.com\/Rigicon","https:\/\/www.threads.com\/@rigiconurology","https:\/\/www.linkedin.com\/company\/rigicon\/","https:\/\/www.wikidata.org\/wiki\/Q141595822"],"description":"Rigicon es un fabricante especializado con sede en EE. UU. de dispositivos de urolog\u00eda prot\u00e9sica: pr\u00f3tesis de pene, esf\u00ednteres urinarios artificiales y pr\u00f3tesis testiculares, comercializados en m\u00e1s de 75 pa\u00edses.","email":"operations@rigicon.com","telephone":"+1 (888) 202-9790","legalName":"Rigicon, Inc.","vatID":"81-3545645","taxID":"81-3545645","duns":"045247683"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/glossary-term\/12067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/glossary-term"}],"about":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/types\/glossary-term"}],"wp:attachment":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/media?parent=12067"}],"wp:term":[{"taxonomy":"glossary-category","embeddable":true,"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/glossary-category?post=12067"},{"taxonomy":"glossary-product","embeddable":true,"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/glossary-product?post=12067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}